Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease (Q51320144)
Jump to navigation
Jump to search
scientific article published on 22 July 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease |
scientific article published on 22 July 2014 |
Statements
Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease (English)
1 reference
J-F Yale
1 reference
G Bakris
1 reference
B Cariou
1 reference
J Nieto
1 reference
E David-Neto
1 reference
D Yue
1 reference
E Wajs
1 reference
K Figueroa
1 reference
J Jiang
1 reference
G Law
1 reference
K Usiskin
1 reference
G Meininger
1 reference
DIA3004 Study Group
1 reference
22 July 2014
1 reference
16
1 reference
10
1 reference
1016-1027
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference